RiverFront Investment Group’s Boeing BA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Buy
7,003
+1,949
+39% +$434K 0.02% 196
2026
Q1
$1.01M Buy
5,054
+2,125
+73% +$484K 0.02% 196
2025
Q4
$636K Sell
2,929
-1,972
-40% -$406K 0.01% 211
2025
Q3
$1.06M Buy
4,901
+425
+9% +$95.8K 0.02% 148
2025
Q2
$938K Buy
4,476
+289
+7% +$54.6K 0.02% 153
2025
Q1
$714K Buy
4,187
+1,478
+55% +$256K 0.02% 162
2024
Q4
$479K Buy
2,709
+84
+3% +$13.2K 0.01% 166
2024
Q3
$399K Buy
2,625
+325
+14% +$55.7K 0.01% 165
2024
Q2
$419K Hold
2,300
0.01% 126
2024
Q1
$444K Buy
2,300
+300
+15% +$61.6K 0.01% 98
2023
Q4
$521K Hold
2,000
0.02% 94
2023
Q3
$383K Hold
2,000
0.01% 94
2023
Q2
$422K Hold
2,000
0.01% 95
2023
Q1
$425K Hold
2,000
0.02% 91
2022
Q4
$381K Hold
2,000
0.09% 86
2022
Q3
$242K Hold
2,000
0.01% 86
2022
Q2
$273K Hold
2,000
0.01% 92
2022
Q1
$383K Hold
2,000
0.01% 91
2021
Q4
$403K Hold
2,000
0.01% 86
2021
Q3
$440K Hold
2,000
0.01% 71
2021
Q2
$479K Buy
+2,000
New +$484K 0.01% 72

Other funds holding BA

RiverFront Investment Group's BA Position: Q2 2026 in Review

RiverFront Investment Group increased its Boeing (BA) stake by 39% in Q2 2026, buying an estimated $434K and bringing the position to 7,003 shares worth $1.52M. The position accounts for 0.02% of the portfolio, ranked #196.

RiverFront Investment Group first reported a position in BA in Q2 2021 and has held it in 21 quarters since. 2,618 funds tracked by Wall St. Rank hold BA as of Q2 2026.

  • RiverFront Investment Group held 7,003 shares of Boeing worth $1.52M as of Q2 2026.
  • RiverFront Investment Group bought 1,949 Boeing shares in Q2 2026, an estimated $434K.
  • Boeing made up 0.02% of RiverFront Investment Group's portfolio in Q2 2026, its #196 holding.
  • RiverFront Investment Group first reported a position in Boeing in Q2 2021 and has held it in 21 quarters since.
  • 2,618 funds tracked by Wall St. Rank held Boeing as of Q2 2026.

Based on RiverFront Investment Group's 13F filing for Q2 2026, filed 29 Jul 2026.